Endoskopie heute 2003; 16(3): 134-139
DOI: 10.1055/s-2003-44277
Originalarbeit

© Georg Thieme Verlag Stuttgart · New York

Reduziertes Pankreatitisrisiko nach endoskopischer Mikrotransducer Manometrie des Sphinkter Oddi: Ein randomisierter Vergleich mit der Perfusionsmanometrie-Technik

Reduced Risk for Pancreatitis After Endoscopic Microtransducer Manometry of the Sphincter of Oddi: A Randomized Comparison with the Perfusion Manometry TechniqueT. Wehrmann1 , N. Stergiou1 , T. Schmitt2 , C. F. Dietrich2 , H. Seifert2
  • 1Abteilung für Innere Medizin I, Lehrkrankenhaus Hannover-Siloah, Deutschland
  • 2Abteilung Innere Medizin II, J. W. Goethe-Universität, Frankfurt am Main, Deutschland
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
17. November 2003 (online)

Zusammenfassung

Mikrotransducer-Manometrie des Sphinkter-Oddi ist eine akzeptable Alternative zur Perfusionsmanometrie in der Beurteilung der motorischen Shinkter-Oddi-Funktion. Sie vermeidet die Volumenbelastung des biliopankreatischen Systems und könnte deshalb mit einem verminderten Pankreatitisrisiko nach manometrischer Untersuchung verbunden sein.
Während einer 2-Jahres-Periode wurde bei 215 Patienten eine Mikrotransducer-Manometrie des Sphinkter-Oddi als alleinige Untersuchung durchgeführt. Die Pankreatitishäufigkeit wurde prospektiv erfasst. Sie betrug insgesamt 4,2 % (9 Fälle: 6 leichte, 2 mittelschwere und 1 schwerer Verlauf, kein Todesfall, keine Operation). In der randomisierten Studie an 130 Patienten betrug die Pankreatitisfrequenz nach Mikrotransducer-Manometrie 3,1 % und nach Perfusionsmanometrie 13,8 % (p = 0,05), so dass die endoskopische Mikrotransducer-Manometrie des Sphinkter-Oddi mit einem geringeren Pankreatitisrisiko verbunden ist als die Perfusionsmanometrie.

Abstract

Endoscopic microtransducer manometry of the sphincter of Oddi has been shown to be a reliable alternative to perfusion manometry for evaluating sphincter of Oddi motor function. It avoids volume loading of the biliopancreatic system, and may therefore be associated with al lower risk of inducing postmanometry pancreatitis. During a 2-year period, microtransducer meanometry of the sphincter of Oddi was carried out in 215 patients as the sole procedure in all. The frequency of pancreatitis was assessed prospectively. During the 2-year period, nine cases of pancreatitis (a pancreatitis frequency of 4.2 %) were observed after microtransducer manometry, and most were of mild degree (six mild, two moderate, and one severe). No deaths occurred, and no surgical procedures were required.
In the randomised part of the study. The frequency of pancreatitis after microtransducer manometry was 3.1 %, compared with 13.8 % after perfusion manometry (< 0.05).
In Endoscopic microtransducer manometry of the sphincter of Oddi is associated with a lower risk for postmanometry panfreatitis than standard perfusion manometry.

Literatur

  • 1 Albert M B, Steinberg W M, Irani S K. Severe acute pankcreatitis complicating sphincter of Oddi manometry.  Gastrointest Endosc. 1988;  34 342-345
  • 2 Christoforidis E, Goulimaris I, Kanellos I. et al . Post-ERCP pancreatitis and hyperamylasaemia: patient-related and operative risk factors.  Endoscopy. 2002;  34 286-292
  • 3 Clouse R E, Staiano A, Alrakawi A, Haroian L. Application of topographica l methods to clinical esophageal manometry.  Am J Gastroenterol. 2000;  95 2720-2730
  • 4 Cotton P B, Lehman G A, Vennes J. et al . Endoscopic sphincterotomy complications and their management: an attempt at consensus.  Gastrointest Endosc. 1991;  37 383-393
  • 5 Dickinson R J, Davies S. Post-ERCP pancreatitis and hyperamylasaemia: the role of operative and patient.  Eur J Gastroenterol Hepatol. 1998;  10 423-428
  • 6 Freeman M L, DiSario J A, Nelson D B. et al . Risk factors for post-ERCP pancreatitis: a prospective, multicenter study.  Gastrointest Endosc. 2001;  54 425-434
  • 7 Freeman M L, Nelson D B, Sherman S. et al . Complications of endoscopic biliary sphincterotomy.  N Engl J Med. 1996;  335 909-918
  • 8 Goff J S. Effect of propofol on human sphincter of Oddi.  Dig Dis sci. 1995;  40 2354-2367
  • 9 Gottlieb K, Sherman S. ERCP and endoscopic biliary sphincterotomyinduced pancreatitis.  Gastrointest Endosc Clin N Am. 1998;  8 87-114
  • 10 Johnson G K, Geenen J E, Johanson J F. et al . Evaluation of post-ERCP pancreatitis: potential causes noted during controlled study of differing contrast media.  Gastrointest Endosc. 1997;  46 217-222
  • 11 King C E, Kalvaria I, Suinsky C A. Pancreatitis due to endoscopic biliary manometry: proceed with caution (abstract).  Gastroenterology. 1988;  94 227
  • 12 Kozarek R A. Biliary dyskinesia: are we any closer to defining the entity?.  Gastroinetst Endosc Clin N Am. 1993;  3 167-178
  • 13 Laugier R. Dynamic endoscopic manometry of the response to secretin in patients with chronic pancreatitis.  Endoscopy. 1994;  26 222-227
  • 14 Lperfido S, Angelini G, Benedetti G. et al . Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study.  Gastrointest Endosc. 1998;  48 1-10
  • 15 Maldonado M E, Brady P G, Mamel J J, Robinson B. Incidence of pancreatitis in patients undergoing sphincter of Oddi manometry.  Am J Gastroenterol. 1999;  94 387-390
  • 16 Mehta S N, Pavone E, Barku J S, Bouchard S, Barkun A N. Predictors of post-ERCP complications in patients with suspected Choledocholithiasis.  Endoscopy. 1998;  30 457-463
  • 17 Meshkinpour H, Kay L, Mollot M. The role of the flow-rate of the pneumohydraulic system on post-sphincter of Oddi manometry.  J Clin Gastroenterol. 1992;  14 236-239
  • 18 Ochi T, Nakazawa S, Naito Y, Tsukamoto Y. Endoscopic manometry of the sphincter of Oddi and pancreatic duct in patients with papillary stenosis.  Endoscopy. 1991;  23 255-258
  • 19 Ponchon T, Pilleul F. Diagnostic ERCP.  Enoscopy. 2002;  34 29-42
  • 20 Rabenstein T, Schneider H T, Bulling D. et al . Analysis of risk factors associated with endoscopic sphincterotomy techniques: preliminary resultes of a prospective study, with emphasis oh the reduced risk of acute pancreatitis with low-dose anticoagulation treatment.  Endoscopy. 2000;  32 10-19
  • 21 Rolny P, Anderberg B, Ihse I, Olaison G, Arvill A. Pancreatitis after sphincter of Oddi manometry.  Gut. 1990;  31 821-824
  • 22 Schmitt T, Seifert H, Dietrich C F, Caspary W F, Wehrmann T. Sedation with propofol during endoscopic sphincter of Oddi manometry.  Z Gastroenterol. 1999;  37 219-227
  • 23 Scicchitano J, Saccone G T, Baker R A, Roberts-Thomson I C, Toouli J. How safe is endoscopic sphincter of Oddi manometry?.  J Gastroenterol Hepatol. 1995;  10 3334-3336
  • 24 Sherman S, Hawes R H, Troiano F P, Lehman G A. Pancreatitis following bile duct sphincter of Oddi manometry: utility of the aspirating catheter.  Gastroinest Endosc. 1992;  38 347-350
  • 25 Sherman S, Lehman G A. ERCP- and endoscopic sphincterotomy-in-duced pancreatitis.  Pancreas. 1991;  6 350-367
  • 26 Sherman S, Troiano F P, Hawes R H. et al . Sphincter of Oddi manometry: decreased risk of clinicalpancreatitis with us of a modified aspirating catheter.  Gastrointest Endosc. 1990;  36 462-466
  • 27 Steinberg W M. Sphincter of Oddi dysfunction: a clinical controversy.  Gastroenterology. 1988;  95 1409-1415
  • 28 Tanaka M, Ikeda S, Nakayama F. Continuous measurement of common bile duct pressure with an indwelling microtransducer catheter introduce by duodenoscopy: new diagnostic aid for post-cholecystectomy dyskinesia - a preliminary report.  Gastrointest Endosc. 1983;  29 83-86
  • 29 Tanaka M, Ikeda S, Nakayama F. Nonoperative measurement of pancreatic and common bile duct pressure with a microtransducer catheter and effects of duodenoscopic shpincterotomy.  Dig Dis Sci. 1981;  26 545-552
  • 30 Tanaka M, Ikeda S. Sphincter of Oddi manometry: comparison of microtransducer and perfusion methods.  Endoscopy. 1988;  20 184-188
  • 31 Trap R, Adamsen S, Hart-Hansen O, Henrikssen M. Severe and fatal complications after diagnostic and therapeutic ERCP: a prospective series of claims to insurance covering public hostpitals.  Endoscopy. 1999;  31 125-130
  • 32 Vondrasek P, Eberhardt G, Classen M. Endoscopic semiconductor manometry.  Int J Med. 1974;  3 188-192
  • 33 Wehrmann T, Lembcke B, Caspary W F, Seifert H. Intravenous sedation with propofol during routine ERCP: a prospective, randomized trial.  Gastrointest Endosc. 1999;  49 677-683
  • 34 Wehrmann T, Marek S, Hanisch E, Lembcke B, Caspary W F. Causes and management of recurrent biliary pain after successful nonoperative gallstone treatment.  Am J Gastroenterol. 1997;  92 132-138
  • 35 Wehrmann T, Seifert H, Hagenmüller F, Jung M, Caspary W F. Endoscopic sphincter of Oddi manometry: does scepticism vanish.  Z Gastroenterol. 1996;  34 17-25
  • 36 Wehrmann T, Schmitt T, Schönfeld A, Caspary W F, Seifert H. Endoscopicsphincter of Oddi manometry with a portable electronic microtransducer system: comparison with the perfusion manometry method and routine clinical application.  Endoscopy. 2000;  32 444-451
  • 37 Wehrmann T, Wendler O G, Jung M, Caspary W F. Risk factors of endoscopic manometry in patients with suspected sphincter of Oddi dysfunction.  Dtsch Med Wochenschr. 1997;  122 808-814

Prof. Dr. med. T Wehrmann

Medizinische Klinik I

Klinikum Hannover-Siloah

Roesebeckstr. 15

30449 Hannover

Telefon: 05 11/9 27 22 31

Fax: 05 11/9 27 26 69

eMail: twehrmann@ hotmail.com

    >